Baird Exits Investment in Accuri Cytometers
Venture capital fund Baird Venture Partners has exited its investment in Accuri Cytometers, selling the company to Becton, Dickinson and Company. Financial terms of the deal were not released. The deal is expected to close in the second quarter of 2011. Ann Arbor, Mich.-based Accuri has raised upwards of $32 million from investors. Baird led the company’s Series B financing round for Accuri in May 2007 and participated in subsequent financing rounds.
Bycnolan
8 February 2011•3 mins read
